There have been several studies on the short-term effects of air pollution on hospital admissions ([@b3-ehp0114-001018], [@b4-ehp0114-001018]; [@b11-ehp0114-001018]; [@b15-ehp0114-001018]; [@b16-ehp0114-001018]), but most have examined single cities. Such single-city studies have been criticized for being applicable only to the city under study and for using different modeling approaches. These comments have led to multicity meta-analyses where the results are pooled---for example, the National Morbidity, Mortality, and Air Pollution Study (NMMAPS) conducted on behalf of the Health Effects Institute in the United States and the APHEA (Air Pollution and Health: A European Approach) studies in Europe. NMMAPS examined the associations between daily hospital counts for cardiovascular admissions in the elderly and air pollutants in 14 cities in different regions of the United States ([@b8-ehp0114-001018]; [@b16-ehp0114-001018]). The APHEA studies have taken place in two stages, and the latest (APHEA2) comprised eight European cities in the investigation of associations of air pollution on daily cardiovascular admissions ([@b11-ehp0114-001018]). Multicity studies have also been conducted in Canada ([@b3-ehp0114-001018], [@b4-ehp0114-001018]).

Despite these studies, the strength of the association between outdoor air pollution and health effects is still unclear because of the complexity of the time-series modeling. In addition, when multiple pollutants have been examined, the independent effects of each pollutant are usually addressed in multipollutant models, but these are sensitive to the modeling assumptions. If the association with one pollutant is nonlinear or varies by season, then a two-pollutant model assuming a linear relationship with each pollutant might not give the independent effect of the second pollutant. Therefore, the case--crossover design ([@b12-ehp0114-001018]), which is less sensitive to model assumptions, is more appropriate. This method investigates the effects of acute exposures and can also examine both multiple exposures and interactions between exposures. It has been applied to the analysis of the acute effects of environmental exposures, especially air pollution ([@b21-ehp0114-001018]). The method matches case days to nearby control days and hence controls for covariates that change slowly over time (e.g., age, smoking behavior, and usual diet). Such matching also controls for seasonal variation and time trends in the health event ([@b2-ehp0114-001018]).

In this study we aimed to find associations between outdoor air pollutant and cardiovascular disease (as measured by counts of hospital admissions) in cities in Australia and New Zealand. The study used two age groups, ≥ 65 years of age (elderly) and 15--64 years of age, although the focus here is on the elderly. The study also examined differences in the associations between cities.

Materials and Methods
=====================

Data collection
---------------

Daily hospital and pollution data were collected for the years 1998 through 2001 in five of the largest cities in Australia (Brisbane, Canberra, Melbourne, Perth, Sydney) and two cities in New Zealand (Auckland, Christchurch). In 2001, these cities covered 53% of the Australian population and 44% of the New Zealand population.

Cardiovascular health data and air pollution data
-------------------------------------------------

Health data were collected for all cardiovascular emergency hospital admissions from state government health departments in Australia and the New Zealand Health Information Service (Ministry of Health). The cardiovascular disease categories used in the study are shown in [Table 1](#t1-ehp0114-001018){ref-type="table"}, and summary statistics and demography for each city are shown in [Table 2](#t2-ehp0114-001018){ref-type="table"}.

The pollutants considered were particulate matter \< 2.5 μm in diameter (PM~2.5~) and \<10 μm in diameter (PM~10~) in micrograms per cubic meter; nitrogen dioxide in parts per billion; carbon monoxide in parts per million; and ozone in parts per billion. Tapered element oscillating microbalance (TEOM) air samplers provided the PM data. Daily pollutant levels were calculated by averaging over a network of monitors in each city. The summary statistics for air pollutants and weather are shown in [Table 3](#t3-ehp0114-001018){ref-type="table"}.

CO and NO~2~ were the only pollutants monitored in all seven cities on a daily basis. For PM~2.5~, daily measurements were available in four of the Australian cities: Brisbane, Melbourne, Perth, and Sydney. PM~10~ was measured on a daily basis in these four cities and in Christchurch.

Statistical methods
-------------------

We used the time-stratified case--crossover method to find associations between pollutants and daily counts of hospital admissions ([@b10-ehp0114-001018]). Controls were chosen from strata of length 28 days; days either side of the case day were excluded to reduce the correlation between case and control exposure. The method controlled for long-term trend, seasonal changes, and respiratory epidemics by design. Using covariates, there were additional controls for temperature, current minus previous day's temperature, relative humidity, pressure, extremes of hot and cold (coldest and warmest 1% of days), day of the week, public holiday (yes/no), and day after a public holiday(s) (yes/no). Rainfall was also included in some investigational models.

The pollutant exposure was the average of the current and previous day. Changes in admissions are shown for a one interquartile range (IQR) increase in pollutant, using the mean IQR across cities. This makes the increases from different pollutants more comparable. An IQR increase can be thought of as the difference between a moderately good day and a moderately bad day. The IQRs were 3.8 μg/m^3^ for 24-hr PM~2.5~, 7.5 μg/m3 for 24-hr PM~10~, 5.1 ppb for 24-hr NO~2~, 0.9 ppm for 8-hr CO, and 8.8 ppb for 8-hr O~3~.

To estimate the average effect for all cities, we combined the estimates across cities using a random effects meta-analysis ([@b13-ehp0114-001018]) and quantified the differences (heterogeneity) between cities using the *I*^2^ statistic ([@b9-ehp0114-001018]). *I* ^2^ values \> 80% indicate that differences between cities are high; \> 50%, notable; \> 20%, mild; and \< 20%, small. To test whether one city had an undue influence on the meta-analysis, we used a leave-one-city-out sensitivity analysis ([@b13-ehp0114-001018]).

We examined differences in the increases between cities using a hierarchical model to incorporate variables that differ between cities and therefore could modify the results (effect modifiers) ([@b7-ehp0114-001018]). The increases in admissions in each city were regressed against potential city-level effect modifiers such as average pollutant level, temperature, and percentage of the population ≥ 65 years of age. Differences were examined only where there was notable heterogeneity (defined by *I*^2^ \> 50%).

When a health outcome showed a significant association with more than one pollutant, we ran a multipollutant model using a matched case--crossover approach ([@b20-ehp0114-001018]). Matching is a traditional approach to control for potential confounding in epidemiology. With control days that are both close in time to the case day and also matched on the level of another pollutant, the effect estimate cannot be confounded by the other pollutant. Matched control days were defined as 24-hr PM~2.5~ within 2 μg/m^3^, 24-hr PM~10~ within 3 μg/m3, 24-hr NO~2~ within 1 ppb, 24-hr CO within 0.5 ppm, and temperature within 1°C.

All analyses were conducted using SAS software ([@b19-ehp0114-001018]).

In the absence of an *a priori* opinion of which pollutants were important to health, we used a statistical significance level of 5%, with no correction for multiple comparisons. Although this increased the chances of finding spurious associations, it reduced the chances of missing any important associations during this early stage of investigation of the effects of air pollution in Australia and New Zealand.

In this study we used monitoring data provided by the relevant monitoring agency in each city. The data sets have been used without extensive analysis or corrections beyond the basic quality control needed to ensure data validity for the case--crossover analysis. Some data sets were not fully used (e.g., the PM~10~ data from Auckland) because they did not fully meet the strict requirements of the study but are still regarded as valid data sets for the purposes for which they were gathered.

Results
=======

The associations between pollutants and cardiovascular hospital admissions are shown in [Table 4](#t4-ehp0114-001018){ref-type="table"}. In the elderly, significant associations were found between the pollutants CO, NO~2~, and PM and five categories of cardiovascular disease admissions. Arrhythmia showed no associations in the elderly but did in the 15- to 64-year age group. Stroke was the only disease category to show no associations in either age group. O~3~ was the only pollutant to show no associations.

In elderly admissions, the two largest statistically significant increases were for cardiac failure, with a 6.9% increase for a 5.1-ppb unit increase in NO~2~ and a 6.0% increase for a 0.9-ppm increase in CO.

For the elderly age group, the relative risks for all cardiac admissions associated with CO, NO~2~, PM~2.5~, and PM~10~ are shown for each city and the meta-analysis in [Figure 1](#f1-ehp0114-001018){ref-type="fig"}, which highlights some of the differences in risk among the cities. This heterogeneity is quantified by the *I*^2^ statistics in [Table 4](#t4-ehp0114-001018){ref-type="table"}. The *I*^2^ statistics indicate that more than half of the results had small heterogeneity. Notable heterogeneity was more often observed in the elderly group.

[Table 5](#t5-ehp0114-001018){ref-type="table"} shows a much reduced *I*^2^ when Sydney was left out for the association between CO and cardiac admissions. [Figure 1A](#f1-ehp0114-001018){ref-type="fig"} shows that the association in Sydney was much larger than in the other cities. The association was also larger in Perth, but the confidence intervals (CIs) were wider. [Table 5](#t5-ehp0114-001018){ref-type="table"} and [Figure 1B](#f1-ehp0114-001018){ref-type="fig"} show that when Christchurch was left out, the association between NO~2~ and cardiac admissions was similar for the remaining cities.

Statistically significant effect modifiers were found only for associations with PM~2.5~. For cardiac admissions, there was a greater association with PM~2.5~ in cities with less humidity. For cardiac failure, there was a greater association with PM~2.5~ in cities with higher pressure and a greater percentage of elderly.

Multipollutant results using a matched case--crossover analysis are shown in [Table 6](#t6-ehp0114-001018){ref-type="table"}. None of the estimated increases changed greatly when cases and controls were matched on temperature. The estimated increase due to NO~2~ fell greatly when cases and controls were matched on CO.

Discussion
==========

Cardiovascular admissions in the elderly
----------------------------------------

This study found many associations between air pollution and cardiovascular admissions in cities in Australia and New Zealand. For every condition but arrhythmia, the increases in hospital admissions were greater in the elderly than in the younger age group ([Table 4](#t4-ehp0114-001018){ref-type="table"}), most likely because the elderly are a frailer population with probable preexisting heart problems. The frailty of the elderly is also the most likely reason that they did not show increases in arrhythmia. Arrhythmia and cardiac failure are related conditions because atrial fibrillation is a type of arrhythmia and may precipitate cardiac failure in elderly people ([@b6-ehp0114-001018]). Hence, exposure to NO~2~ and CO that led to arrhythmia in the younger age group led to the more serious condition of cardiac failure in the elderly.

We found associations at concentrations below normal air quality health guidelines ([Table 3](#t3-ehp0114-001018){ref-type="table"}). This suggests that current air pollution guidelines need to be revised. There is good reason to believe that lowering air pollution levels would lead to improvements in cardiovascular health.

This results presented here are based on statistically significant findings. Although this is not ideal practice, there is limited space in this article; a complete set of results will be available in a forthcoming report (Expansion of the Multi-City Mortality and Morbidity Study, National Environment Protection Council). A non-statistically significant association does not, of course, mean that a relationship does not exist. This is particularly important for those admissions with smaller numbers of events and hence less power (e.g., stroke in the younger age group).

Differences among cities
------------------------

Differences in the associations between cities in this study were mostly not notable (*I*^2^ \< 50%). This suggests that the relationship between exposure and disease was often similar. There was more notable heterogeneity in the elderly population, which is partly due to the greater size of the associations in this age group.

In an attempt to explain the notable heterogeneity, we used effect-modifier analyses. However, we found effect modifiers only for associations with PM~2.5~. The effect of PM~2.5~ in Australian cities depended on the percentage of the elderly and average weather conditions. Less average humidity and higher average pressure led to a greater association. To investigate these modifications further, we reran the case--crossover models in each city including an interaction term for 24-hr PM~2.5~ and rainfall (results not shown). Higher rainfall led to a smaller association between cardiovascular admissions and PM~2.5~ in all four cities. This is not surprising, considering that rainfall is a primary removal mechanism for PM~10~ and PM~2.5~, but less so for gaseous pollutants.

Comparison with three other large studies
-----------------------------------------

The aim and design of this study were similar to those of three other large studies: the APHEA2 study of eight cities in Europe ([@b11-ehp0114-001018]), NMMAPS with 14 U.S. cities ([@b16-ehp0114-001018]), and a Canadian study of 10 cities ([@b4-ehp0114-001018]). The results here for PM pollution in terms of elderly cardiac admissions are similar to those found in APHEA2 and NMMAPS, and congestive heart failure in the Canadian study. For example, we found the mean increase for cardiac admissions for the 15--64-year age group to be less than half that in the older group, a result similar to that of the APHEA2 study. The APHEA2 study also found that the heterogeneity in total cardiac admissions (all ages) was related to the percentage of elderly. However, the results for the confounding effects on PM associations by including CO are different (but PM was not monitored in every city here).

A difference between this study and the three large multicity studies is that emission sources for PM, and therefore the PM composition, differ. For example, [@b5-ehp0114-001018] found significantly higher contributions from sea salt and nonanthropogenic crustal sources for both PM~2.5~ and PM~10~ in Brisbane than in overseas cities.

Another important difference from the other studies is in the statistical methods used here. The NMMAPS and APHEA2 studies used generalized additive models, in which confounding was estimated by adding the copollutant into the model. In the APHEA2 study, the PM~10~ associations were significantly reduced in the multipollutant models by the inclusion of NO~2~ (as found here) and slightly (but becoming statistically insignificant) for CO. However, using black smoke to estimate the PM impacts showed no confounding by CO and much less by NO~2~. There was no significant confounding of the PM associations by CO or NO~2~ found in NMMAPS.

Addressing confounding between pollutants
-----------------------------------------

Instead of using a multipollutant model, we controlled for confounding by matching in the case--crossover analysis. For elderly hospital admissions, the CO associations remained of a similar size when matched with NO~2~. Conversely, the NO~2~ became smaller when matched with CO ([Table 6](#t6-ehp0114-001018){ref-type="table"}).

Matching was also used to control for the important confounder of temperature. The results changed little when matched on temperature, strongly suggesting that the association between air pollution and cardiovascular disease is not confounded by temperature.

Is outdoor air pollution a good indicator of exposure?
------------------------------------------------------

A problem in interpreting the results from this study is that it used outdoor air pollution concentrations measured at fixed-point monitors (ambient concentrations), whereas people spend most of their time indoors. Recent studies in Baltimore, Maryland ([@b18-ehp0114-001018]) and Boston, Massachusetts ([@b17-ehp0114-001018]) indicate that such ambient concentrations may be poor surrogates for actual exposure to air pollution, especially in winter when buildings are more sealed. However, winters in Australia are mild, meaning that people will likely spend more time outdoors and that houses are designed to lose heat rather than trap it. Hence, exposure to the air may be high all year round in Australia (winter exposure in New Zealand may be more similar to that in Baltimore). A similar conclusion was drawn by a study of the effects of cold temperatures on cardiovascular disease ([@b1-ehp0114-001018]). In that study, regions with mild winters showed greater increases in cold-related cardiovascular events than did regions with usually cold winters.

The study in Baltimore also found that ambient concentrations for CO and NO~2~ were often better surrogates for actual exposure to PM than to CO and NO~2~, especially in summer ([@b18-ehp0114-001018]). However, the more recent Boston study did note that there were some correlations between ambient concentrations and actual exposure to these gases in summer ([@b17-ehp0114-001018]). Outdoor concentrations for pollutants such as NO~2~, CO, and PM often arise from the same combustion emissions sources, such as motor exhausts.

CO as a marker for pollution sources
------------------------------------

There is evidence that air pollutants (NO~2~, CO) may trigger fibrillation in people with a history of serious arrhythmia ([@b14-ehp0114-001018]). The effect of CO on cardiovascular disease is well known, with CO replacing oxygen in the blood stream, but at the low CO concentrations prevailing in the cities under study, it cannot be simply assumed that if CO is the "cause" of any effects found here, it is due to this mechanism. The associations found for CO, NO~2~, and PM are not additive, but probably refer to the impacts of a similar pollutant "mix." Given that the CO associations show the least change when matched with the other pollutants ([Table 6](#t6-ehp0114-001018){ref-type="table"}), this indicates that the air pollutant mixture arising from emission sources dominating the CO emissions (usually human combustion sources) is the primary cause of the association, not the effect of CO itself.

Conclusions
===========

For both Australian and New Zealand cities, the results show that increases in outdoor concentrations of CO, NO~2~, and PM have significant associations with increases in cardiovascular admissions for adults, especially the elderly (≥ 65 years of age). Associations were found at concentrations below normal air quality health guidelines. There were significant associations between air pollution and arrhythmia admissions in the younger age group, which were not apparent for the elderly. For the elderly, there were significant associations between air pollution increases and increases in hospital admissions for ischemic heart disease and myocardial infarction, and these were not apparent for the younger group. Atrial fibrillation can precipitate cardiac failure, especially in the elderly, and a significant relationship has been identified here in the adult age group (15--64 years) between increases in hospital admissions for arrhythmia and increases in air pollution.

The associations for NO~2~ appear to be stronger in Australian than in New Zealand cities, whereas those of CO are similar for cities in both countries. In Australian cities, PM~10~ and PM~2.5~ had a similar association, apart from that for arrhythmia. These PM~2.5~ associations differed among cities due to different climate conditions for humidity (the lower the humidity, the greater the association).

It is difficult to separate the associations for different pollutants because there are common emission sources for CO, NO~2~, and PM (e.g., motor vehicle exhausts). Also, outdoor concentrations are often not good surrogates for actual exposure, with outdoor levels for the gases sometimes being good surrogates for actual exposure to PM, especially in summer.
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###### 

Cardiovascular disease categories and *International Classification of Disease* (ICD) codes.

  Disease category               ICD-9      ICD-10
  ------------------------------ ---------- --------------------------------------------------------------------------------------------------------
  Arrhythmia                     427        I46--I49
  Cardiac disease                390--429   I00--I52, I97.0, I97.1, I98.1
  Cardiac failure                428        I50
  Ischemic heart disease         410--413   I20, I21, I22, I24, I25.2
  Myocardial infarction          410        I21, I22
  Stroke                         430--438   I60--I66, I67 (excluding I67.0, I67.3), I68 (excluding I68.0), I69, G45 (excluding G45.3), G46
  Total cardiovascular disease   390--459   I00--I99 (excluding I67.3, I68.0, I88, I97.8, I97.9, I98.0), G45 (excluding G45.3), G46, M30, M31, R58

ICD-9, 9th Revision, used January--June 1998; ICD-10, 10th Revision, used July 1998--December 2001.

###### 

Summary statistics for demographic and hospital admission rates per million people (1998--2001).

                                               Auckland       Brisbane       Canberra       Christchurch   Melbourne      Perth          Sydney
  -------------------------------------------- -------------- -------------- -------------- -------------- -------------- -------------- --------------
  Demographic data                                                                                                                       
   Total population                            1,158,891      1,627,535      311,518        316,224        3,366,542      1,339,993      3,997,321
   Percentage of population \> 65 years        10.0           11.0           8.3            13.7           12.1           11.3           11.9
  Daily hospital admissions \[mean (range)\]                                                                                             
   Cardiovascular                                                                                                                        
    15--64 years                               11.5 (3--31)   9.3 (2--19)    17.6 (0--67)   10.2 (0--32)   7.7 (2--14)    7.9 (1--17)    7.7 (3--14)
    ≥65 years                                  18.1 (4--35)   18.6 (8--33)   20.0 (0--61)   26.2 (0--60)   16.3 (8--28)   18.8 (6--35)   15.5 (7--26)
   Cardiac                                                                                                                               
    15--64 years                               8.6 (1--24)    7.5 (1--17)    10.5 (0--42)   7.3 (0--28)    5.5 (1--11)    6.0 (0--14)    5.9 (2--11)
    ≥65 years                                  12.8 (2--27)   14.0 (5--29)   14.1 (0--45)   18.1 (0--44)   11.5 (5--21)   13.7 (3--27)   11.1 (5--20)
   Ischemic heart disease                                                                                                                
    15--64 years                               4.5 (0--14)    4.5 (0--11)    4.8 (0--26)    4.5 (0--19)    3.2 (1--6)     3.4 (0--9)     3.1 (0--7)
    ≥65 years                                  6.5 (0--18)    7.6 (1--18)    6.1 (0--26)    10.4 (0--35)   5.7 (2--11)    6.7 (1--15)    4.9 (2--10)
   Stroke                                                                                                                                
    15--64 years                               1.6 (0--7)     0.9 (0--6)     1.0 (0--10)    1.8 (0--13)    1.1 (0--3)     1.0 (0--5)     1.0 (0--3)
    ≥65 years                                  3.5 (0--10)    3.2 (0--9)     2.6 (0--16)    5.5 (0--22)    3.5 (1--10)    3.4 (0--9)     3.1 (1--7)
   Arrhythmia                                                                                                                            
    15--64 years                               2.0 (0--9)     1.3 (0--6)     2.0 (0--19)    1.3 (0--13)    1.0 (0--4)     1.1 (0--6)     1.2 (0--4)
    ≥65 years                                  2.5 (0--9)     2.1 (0--7)     2.5 (0--16)    2.7 (0--16)    1.8 (0--5)     2.2 (0--7)     1.9 (0--5)
   Cardiac failure                                                                                                                       
    15--64 years                               0.8 (0--5)     0.5 (0--3)     0.4 (0--6)     0.4 (0--9)     0.5 (0--3)     0.5 (0--4)     0.4 (0--2)
    ≥65 years                                  2.7 (0--10)    3.2 (0--10)    2.3 (0--13)    3.7 (0--22)    3.3 (1--7)     3.7 (0--12)    2.9 (0--9)
   Myocardial infarction                                                                                                                 
    15--64 years                               1.5 (0--7)     1.4 (0--5)     1.2 (0--10)    1.8 (0--13)    1.2 (0--4)     1.3 (0--5)     1.1 (0--3)
    ≥65 years                                  2.3 (0--9)     2.4 (0--7)     1.4 (0--13)    4.7 (0--25)    1.9 (0--6)     2.4 (0--9)     1.7 (0--4)

###### 

Summary statistics for daily air pollutant and weather data (1998--2001).

                                            Auckland                                                          Brisbane            Canberra          Christchurch        Melbourne           Perth               Sydney
  ----------------------------------------- ----------------------------------------------------------------- ------------------- ----------------- ------------------- ------------------- ------------------- -------------------
  Daily pollutant levels \[mean (range)\]                                                                                                                                                                       
   24-hr PM~2.5~ (μg/m^3^)                  11.0[a](#tfn2-ehp0114-001018){ref-type="table-fn"} (2.1--37.6)    9.7 (3.2--122.8)    ---               ---                 8.9 (2.8--43.3)     8.1 (1.7--29.3)     9.4 (2.4--82.1)
   No. of monitors                          1                                                                 1                   0                 0                   2                   2                   3
   24-hr PM~10~ (μg/m^3^)                   18.8[a](#tfn2-ehp0114-001018){ref-type="table-fn"} (3.2--101.4)   16.5 (3.8--50.2)    ---               20.6 (1.3--156.3)   16.6 (3.1--71.1)    16.5 (4.4--68.9)    16.6 (3.7--104.7)
   No. of monitors                          6                                                                 4                   0                 2                   4                   1                   11
   1-hr NO~2~ (ppb)                         19.1 (4.2--86.3)                                                  17.3 (4--44.1)      17.9 (0--53.7)    15.7 (1.2--54.6)    23.2 (4.4--62.5)    21.3 (4.4--48)      22.6 (5.2--51.4)
   24-hr NO~2~ (ppb)                        10.2 (1.7--28.9)                                                  7.6 (1.4--19.1)     7.0 (0--22.5)     7.1 (0.2--24.5)     11.7 (2--29.5)      9.0 (2--23.3)       11.5 (2.5--24.5)
   No. of monitors                          2                                                                 7                   1                 1                   8                   5                   13
   8-hr CO (ppb)                            2.1 (0.2--7.9)                                                    1.7 (0--7)          0.9 (0--5.8)      0.5 (0--5.4)        1.0 (0.1--8)        1.0 (0.1--4)        0.8 (0--4.5)
   No. of monitors                          3                                                                 1                   1                 2                   3                   3                   4
   1-hr O~3~ (ppb)                          ---                                                               31.5 (7--92.3)      ---               ---                 23.8 (1.7--85.4)    33.6 (13--85)       31.7 (3.2--126.7)
   4-hr O~3~ (ppb)                          ---                                                               28.9 (5.4--75.2)    ---               ---                 21.8 (1.3--73.1)    31.3 (10.6--72.8)   28.9 (2.2--105.1)
   8-hr O~3~ (ppb)                          ---                                                               25.5 (3.7--58.4)    ---               ---                 19.0 (0.8--63)      28.5 (8--64)        24.9 (1.4--86.8)
   No. of monitors                          0                                                                 7                   0                 0                   8                   3                   12
  Weather                                                                                                                                                                                                       
   Temperature (°C)                         15.7 (6.3--24.1)                                                  20.0 (9.5--30.4)    13.7 (1--28)      11.6 (0--27.2)      15.3 (5.9--31.8)    18.2 (8.2--32.3)    17.8 (8.5--30.1)
   Relative humidity (%)                    79.1 (52.1--100)                                                  72.4 (29.3--96.3)   69.9 (24.1--97)   75.9 (31--99)       68.7 (25.1--95.5)   67.8 (28--98.5)     70.6 (26.3--97.1)
   Rain (mm)                                3.06 (0--71.6)                                                    2.6 (0--128.9)      1.82 (0--79.8)    1.56 (0--54.8)      1.99 (0--43.07)     2.08 (0--104.0)     2.71 (0--137.1)

The Auckland region does not run TEOMs but had an extensive Hi-Vol network. The PM data for Auckland were recorded once every 6 days and were not suitable for the case--crossover analysis.

###### 

Significant increases in cardiovascular hospital admissions by age group using a meta-analysis of case--crossover estimates (urban Australia and New Zealand, 1998--2001).

                                                                                                   Elderly (≥65 years)   Adults (15--64 years)                       
  ------------------------ ----------------------------------------------------------------------- --------------------- ----------------------- ------------------- ------
  Arrhythmia               24-hr NO~2~ (ppb)                                                       0.4 (−1.8 to 2.6)     0                       5.1 (2.2 to 8.1)    0
                           8-hr CO (ppm)                                                           0.1 (−1.8 to 2.1)     10.8                    2.5 (0.1 to 4.9)    5.6
  Cardiac                  24-hr PM~2.5~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}   1.9 (1.0 to 2.7)      55.0                    0.6 (−0.2 to 1.4)   0
                           24-hr PM~10~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}    1.1 (0.2 to 2.0)      32.9                    0.3 (−0.8 to 1.3)   0
                           24-hr NO~2~ (ppb)                                                       3.4 (1.9 to 4.9)      54.1                    2.2 (0.9 to 3.4)    0
                           8-hr CO (ppm)                                                           2.8 (1.3 to 4.4)      73.5                    1.7 (0.5 to 2.9)    24.7
  Cardiac failure          24-hr PM~2.5~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}   3.6 (1.8 to 5.4)      58.6                    3.0 (−0.1 to 6.1)   0
                           24-hr PM~10~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}    3.4 (2.1 to 4.7)      0                       2.1 (−1.7 to 6.1)   0
                           24-hr NO~2~ (ppb)                                                       6.9 (2.2 to 11.8)     61.3                    4.6 (0.1 to 9.3)    0
                           8-hr CO (ppm)                                                           6.0 (3.5 to 8.5)      61.6                    4.2 (0.6 to 7.8)    0
  Ischemic heart disease   24-hr PM~2.5~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}   1.6 (0.7 to 2.4)      3.6                     0.2 (−0.9 to 1.3)   0
                           24-hr NO~2~ (ppb)                                                       2.5 (1.0 to 4.1)      19.7                    0.7 (−1.0 to 2.4)   0
                           8-hr CO (ppm)                                                           2.3 (0.9 to 3.8)      35.9                    1.6 (−0.6 to 3.9)   53.5
  Myocardial infarction    24-hr PM~2.5~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}   2.7 (1.3 to 4.2)      0                       1.2 (−0.6 to 3.1)   0
                           24-hr NO~2~ (ppb)                                                       4.4 (1.0 to 8.0)      38.2                    1.7 (−1.1 to 4.7)   0
                           8-hr CO (ppm)                                                           2.9 (0.8 to 4.9)      21.3                    1.8 (−0.7 to 4.3)   9.2
  Total cardiovascular     24-hr PM~2.5~ (μg/m^3^)[c](#tfn6-ehp0114-001018){ref-type="table-fn"}   1.3 (0.6 to 2.0)      51.9                    0.2 (−0.5 to 0.9)   0
                           24-hr NO~2~ (ppb)                                                       3.0 (2.1 to 3.9)      18.4                    1.7 (0.6 to 2.8)    0
                           8-hr CO (ppm)                                                           2.2 (0.9 to 3.4)      69.5                    1.2 (0.3 to 2.1)    6.6

CI, confidence interval.

Percent increase in admissions for an IQR increase in pollutant using the average over the current and previous day.

*I*^2^ is the percentage of total variation in the estimated increase that is due to heterogeneity between cities.

PM~2.5~ was measured on a daily basis only in Brisbane, Melbourne, Perth, and Sydney; and PM~10~, in these cities and Christchurch.

###### 

Significant increases in cardiac hospital admissions for the elderly age group for the cities: results from the leave-one-out sensitivity analysis.

                            8-hr CO          24-hr NO~2~   24-hr PM~2.5~                                                              
  ------------------------- ---------------- ------------- ---------------- ------ -------------------------------------------------- --------------------------------------------------
  Auckland                  2.9 (1.1--4.7)   77.7          3.6 (2.1--5.2)   54.1   [](#tfn7-ehp0114-001018){ref-type="table-fn"}---   [](#tfn7-ehp0114-001018){ref-type="table-fn"}---
  Brisbane                  3.2 (1.5--4.9)   71.5          2.8 (0.5--5.1)   61.7   2.2 (1.6--2.9)                                     0.0
  Canberra                  3.1 (1.5--4.7)   76.1          3.5 (2.0--5.1)   56.8   [](#tfn7-ehp0114-001018){ref-type="table-fn"}---   [](#tfn7-ehp0114-001018){ref-type="table-fn"}---
  Christchurch              3.0 (1.3--4.8)   76.5          4.0 (3.0--5.0)   7.4    [](#tfn7-ehp0114-001018){ref-type="table-fn"}---   [](#tfn7-ehp0114-001018){ref-type="table-fn"}---
  Melbourne                 2.8 (1.0--4.7)   77.8          2.6 (0.2--5.2)   61.6   1.6 (0.6--2.8)                                     57.6
  Perth                     2.6 (0.9--4.2)   76.3          3.0 (1.3--4.7)   59.2   1.7 (0.7--2.6)                                     61.4
  Sydney                    2.2 (1.2--3.1)   21.7          2.8 (1.0--4.7)   55.0   1.9 (0.6--3.2)                                     69.7
  Both New Zealand cities   3.2 (1.0--5.3)   80.8          4.2 (3.3--5.2)   0.0    1.9 (1.0--2.7)                                     55.0

, not collected.

Percent increase in admissions for an IQR increase in pollutant using the average over the current and previous day.

*I*^2^ is the percentage of total variation in the estimated increase that is due to heterogeneity between cities.

###### 

Multipollutant models: statistically significant increases in cardiac hospital admissions and increases after matching for other exposures.

  Age group/single pollutant                                              Matched exposure            Increase \[%[a](#tfn10-ehp0114-001018){ref-type="table-fn"} (95% CI)\]
  ----------------------------------------------------------------------- --------------------------- ------------------------------------------------------------------------
  Cardiac admissions (15--64 years of age)                                                            
   24-hr average NO~2~                                                    8-hr average CO (maximum)   −0.0 (−1.6 to 1.5)
                                                                          Average temperature         2.4 (0.9--4.0)
                                                                          Unmatched                   2.2 (0.9--3.4)
   8-hr average CO (max)                                                  24-hr average NO~2~         2.4 (−1.4 to 6.3)
                                                                          Average temperature         1.9 (0.6--3.3)
                                                                          Unmatched                   1.7 (0.5--2.9)
  Cardiac admissions (≥65 years of age)                                                               
   24-hr average NO~2~                                                    8-hr average CO (maximum)   0.6 (−1.7 to 3.0)
                                                                          Average temperature         3.5 (1.7--5.4)
                                                                          Unmatched                   3.4 (1.9--4.9)
                                                                                                      0.4 (−1.7 to 2.5)
   24-hr average PM~2.5~[b](#tfn11-ehp0114-001018){ref-type="table-fn"}   24-hr average NO~2~         
                                                                          8-hr average CO (maximum)   1.2 (0.0--2.4)
                                                                          Average temperature         1.8 (0.6--3.0)
                                                                          Unmatched                   1.9 (1.0--2.7)
   8-hr average CO (maximum)                                              24-hr average NO~2~         2.8 (0.2--5.4)
                                                                          Average temperature         2.6 (0.9--4.4)
                                                                          Unmatched                   2.8 (1.3--4.4)

Percent increase in admissions for an IQR increase in pollutant using the average over the current and previous day.

PM~2.5~ was measured on a daily basis only in Brisbane, Melbourne, Perth, and Sydney; and PM~10~, in these cities and Christchurch.
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